Lataa...
Comparing Therapeutic Efficacy and Safety of Epoetin Beta and Epoetin Alfa in the Treatment of Anemia in End-Stage Renal Disease Hemodialysis Patients
BACKGROUND: Anemia is one of the most prevalent complications in patients with chronic kidney disease, which is believed to be caused by the insufficient synthesis of erythropoietin by the kidney. This phase III study aimed to compare the efficacy and safety of CinnaPoietin® (epoetin beta, CinnaGen)...
Tallennettuna:
| Julkaisussa: | Am J Nephrol |
|---|---|
| Päätekijät: | , , , , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
S. Karger AG
2018
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6381861/ https://ncbi.nlm.nih.gov/pubmed/30253403 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000493097 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|